Screening intervention to identify eligible patients and improve accrual to phase II-IV oncology clinical trials

Journal of Oncology Practice

Volumn 9, Issue 4, 2013, Pages

  Chen, Leo ^a   Grant, Janice ^a   Cheung, Winson Y ^a   Kennecke, Hagen F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BREAST CANCER; CLINICAL RESEARCH; DIGESTIVE SYSTEM CANCER; ELECTRONIC MEDICAL RECORD; HUMAN; LUNG CANCER; MEDICAL ONCOLOGIST; OUTPATIENT DEPARTMENT; PATIENT IDENTIFICATION; PATIENT PARTICIPATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PHYSICIAN ATTITUDE; SCREENING; UROGENITAL TRACT CANCER;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; CLINICAL TRIALS, PHASE IV AS TOPIC; HUMANS; NEOPLASMS; PATIENT SELECTION; PHYSICIANS; QUESTIONNAIRES;

EID: 84887090529     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000763     Document Type: Article

References (25)

1. National Cancer Institute: Clinical trials search results. //www.cancer.gov/clinicaltrials/search
2. Go RS, Frisby KA, Lee J.A., et al.: Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer 106:426-433, 2005
3. Comis RL, Miller JD, Colaizzi D.D., et al.: Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Clin Oncol 5:50-56, 2009
4. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-2726, 2004
5. Ehrlich PF, Newman KD, Haase G.M., et al.: Lessons learned from a failed multi-institutional randomized controlled study. J Pediatr Surg 37:431-436, 2002
6. Haidich AB, Ioannidis JP: Effect of early patient enrolment on the time to completion and publication of randomized controlled trials. Am J Epidermiol 154: 873-880, 2001
7. Padberg RM: Cancer clinical trial accrual: We have a problem. J Canc Educ 26:403-404, 2011
8. Kitterman DR, Cheng SK, Dilts D.M., et al: The prevalence and economic impact of low-enrolling clinical studies at an academic medical center. Acad Med 86: 1360-1366, 2011
9. Sateren WB, Trimble EL, Abrams J, et al.: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20:2109-2117, 2002
10. Lovato LC, Hill K, Hertert S., et al.: Recruitment for controlled clinical trials: Literature summary and annotated biography. Lancet Oncol 18:328-352, 1997
11. Scoggins JF, Ramsey SD: A national cancer clinical trials system for the 21st century: Reinvigorating the NCI cooperative group program. J Natl Canc Inst 102:1371, 2010
12. Schroen AT, Petroni GR, Wang H, et al.: Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups. Clin Cancer Res 18:256-262, 2012
13. Hudson SV, Momperousse D, Leventhal H: Physician perspectiveson cancer clinical trials and barriers to minority recruitment. Cancer Contr 12:93-96, 2005 (suppl 2)
14. Lara PN Jr., Higdon R, Lim N., et al.: Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 19:1728-1733, 2001
15. Mills EJ, Seely D, Rachlis B., et al.: Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7:141-148, 2006
16. Umutyan A, Chiechi C, Beckett L.A., et al.: Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign. Cancer 112:212-219, 2008
17. Benson AB 3rd, Pregler JP, Bean JA, et al.: Oncologists' reluctance to accrue patients onto clinical trials: An Illinois Cancer Center study. J Clin Oncol 9:2067-2075, 1991
18. Ford E, Jenkins V, Fallowfield L., et al.: Clinicians' attitudes towards clinical trials of cancer therapy. Br J Cancer 104:1535-1543, 2011
19. Jenkins V, Farewell D, Batt L., et al.: The attitudes of 1066 patients with cancer towards participation in randomized clinical trials. Br J Cancer 103:1801-1807, 2010
20. Comis RL, Miller JD, Aldigé CR, et al.: Public attitudes toward participation in clinical trials. J Clin Oncol 21:830-835, 2003
21. Taylor KM, Feldstein ML, Skeel R.T., et al.: Fundamental dilemmas of the randomized clinical trial process: Results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol 12:1796-1805, 1994
22. Embi PJ, Jain A, Clark J., et al.: Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med 165:2272-2277, 2005
23. Thadani SR, Weng C, Bigger J.T., et al.: Electronic screening improves efficiency in clinical trial recruitment. J Am Med Inform Assoc 16:869-873, 2009
24. Weng C, Batres C, Borda T., et al.: A real-time screening alert improves patient recruitment efficiency. AMIA Annu Symp Proc 2011:1489-1498, 2011
25. Rollman BL, Fischer GS, Zhu F, Belnap BH: Comparison of electronic physician prompts versus waitroom case-finding on clinical trial enrolment. J Gen Intern Med 23(4): 447-450, 2008